Загрузка...
Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
We report a 53-year-old man diagnosed with Richter syndrome. He was heavily pretreated and was refractory to prior therapy. He received rituximab and ibrutinib, and achieved a significant response after 1 month of therapy. Our case illustrates the importance of investigation of rituximab and ibrutin...
Сохранить в:
| Опубликовано в: : | Clin Case Rep |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons, Ltd
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527807/ https://ncbi.nlm.nih.gov/pubmed/26273453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.269 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|